Vagus nerve stimulation therapy in partial epilepsy: a review - PubMed

Review

Vagus nerve stimulation therapy in partial epilepsy: a review

Mariangela Panebianco et al. Acta Neurol Belg. 2016 Sep.

Abstract

Epilepsy is a chronic neurological disorder characterized by recurrent, unprovoked epileptic seizures. The majority of people given a diagnosis of epilepsy have a good prognosis, but 20-30 % will develop drug-resistant epilepsy. Vagus nerve stimulation (VNS) is a neuromodulatory treatment that is used as an adjunctive therapy for treating people with medically refractory epilepsy. It consists of chronic intermittent electrical stimulation of the vagus nerve, delivered by a programmable pulse generator (Neuro-Cybernetic Prosthesis). In 1997, the Food and Drug Administration approved VNS as adjunctive treatment for medically refractory partial-onset seizures in adults and adolescents. This article reviews the literature from 1988 to nowadays. We discuss thoroughly the anatomy and physiology of vagus nerve and the potential mechanisms of actions and clinical applications involved in VNS therapy, as well as the management, safety, tolerability and effectiveness of VNS therapy. VNS for partial seizures appears to be an effective and well tolerated treatment in adult and pediatric patients. People noted improvements in feelings of well-being, alertness, memory and thinking skills, as well as mood. The adverse effect profile is substantially different from the adverse effect profile associated with antiepileptic drugs, making VNS a potential alternative for patients with difficulty tolerating antiepileptic drug adverse effects. Despite the passing years and the advent of promising neuromodulation technologies, VNS remains an efficacy treatment for people with medically refractory epilepsy. Past and ongoing investigations in other indications have provided signals of the therapeutic potential in a wide variety of conditions.

Keywords: Neuromodulation; Partial epilepsy; Vagus nerve stimulation.

Similar articles

• Vagus nerve stimulation for partial seizures.

  Panebianco M, Rigby A, Weston J, Marson AG. Panebianco M, et al. Cochrane Database Syst Rev. 2015 Apr 3;2015(4):CD002896. doi: 10.1002/14651858.CD002896.pub2. Cochrane Database Syst Rev. 2015. PMID: 25835947 Free PMC article. Updated. Review.

• Vagus nerve stimulation.

  Schachter SC, Saper CB. Schachter SC, et al. Epilepsia. 1998 Jul;39(7):677-86. doi: 10.1111/j.1528-1157.1998.tb01151.x. Epilepsia. 1998. PMID: 9670894 Review.

• Efficacy of vagus nerve stimulation in posttraumatic versus nontraumatic epilepsy.

  Englot DJ, Rolston JD, Wang DD, Hassnain KH, Gordon CM, Chang EF. Englot DJ, et al. J Neurosurg. 2012 Nov;117(5):970-7. doi: 10.3171/2012.8.JNS122. Epub 2012 Sep 14. J Neurosurg. 2012. PMID: 22978542

• Chronic intermittent vagal nerve stimulation in the treatment of refractory epilepsy: experience in Mexico with 35 cases.

  Alonso-Vanegas MA, Austria-Velásquez J, López-Gómez M, Brust-Mascher E. Alonso-Vanegas MA, et al. Cir Cir. 2010 Jan-Feb;78(1):15-23, 24. Cir Cir. 2010. PMID: 20226124 English, Spanish.

• An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.

  Raspin C, Faught E, Armand J, Barion F, Pollit V, Murphy J, Danielson V. Raspin C, et al. J Med Econ. 2023 Jan-Dec;26(1):189-199. doi: 10.1080/13696998.2023.2171230. J Med Econ. 2023. PMID: 36691763

Cited by

• Neurostimulation as a promising epilepsy therapy.

  Lin Y, Wang Y. Lin Y, et al. Epilepsia Open. 2017 Aug 23;2(4):371-387. doi: 10.1002/epi4.12070. eCollection 2017 Dec. Epilepsia Open. 2017. PMID: 29588969 Free PMC article. Review.

• Non-pharmacological Interventions for Intractable Epilepsy.

  Alqahtani F, Imran I, Pervaiz H, Ashraf W, Perveen N, Rasool MF, Alasmari AF, Alharbi M, Samad N, Alqarni SA, Al-Rejaie SS, Alanazi MM. Alqahtani F, et al. Saudi Pharm J. 2020 Aug;28(8):951-962. doi: 10.1016/j.jsps.2020.06.016. Epub 2020 Jun 29. Saudi Pharm J. 2020. PMID: 32792840 Free PMC article. Review.

• Efficacy and tolerability of vagus nerve stimulation therapy (VNS) in Slovenian epilepsy patients: younger age and shorter duration of epilepsy might result in better outcome.

  Kavčič A, Kajdič N, Rener-Primec Z, Krajnc N, Žgur T. Kavčič A, et al. Acta Clin Croat. 2019 Jun;58(2):255-264. doi: 10.20471/acc.2019.58.02.08. Acta Clin Croat. 2019. PMID: 31819321 Free PMC article.

• Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects.

  Nowakowska M, Üçal M, Charalambous M, Bhatti SFM, Denison T, Meller S, Worrell GA, Potschka H, Volk HA. Nowakowska M, et al. Front Vet Sci. 2022 Jun 16;9:889561. doi: 10.3389/fvets.2022.889561. eCollection 2022. Front Vet Sci. 2022. PMID: 35782557 Free PMC article. Review.

• Ictal heart rate changes and the effects of vagus nerve stimulation for patients with refractory epilepsy.

  Chen W, Meng FG. Chen W, et al. Neuropsychiatr Dis Treat. 2017 Sep 5;13:2351-2356. doi: 10.2147/NDT.S142714. eCollection 2017. Neuropsychiatr Dis Treat. 2017. PMID: 28919768 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal